Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 15/20 | 0.43 |
| ▸ | THRA | P10827 | 14/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | PCNA | P12004 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3145982 | 0.91 | THRB (0.40) | THRBTHRAPPARGPCNA | |
| SCHEMBL3131477 | 0.89 | THRB (0.48) | THRBTHRAPCNAMAPT | |
| SCHEMBL14385501 | 0.85 | THRB (0.37) | THRBTHRAPPARGPCNA | |
| SCHEMBL14386131 | 0.82 | THRA (0.42) | THRBTHRAPCNAMAPTADRB2 | |
| SCHEMBL3142103 | 0.82 | THRB (0.44) | THRBTHRAPCNAMAPT | |
| SCHEMBL3910551 | 0.80 | THRA (0.41) | THRBTHRAPPARG | |
| SCHEMBL3908141 | 0.78 | THRA (0.49) | THRBTHRAMAPT | |
| SCHEMBL3915777 | 0.78 | THRB (0.44) | THRBTHRAPCNA | |
| SCHEMBL3130002 | 0.77 | THRA (0.39) | THRBTHRAPPARG | |
| SCHEMBL3911699 | 0.76 | KMT2A (0.40) | THRBTHRAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1899309-A1 | HETEROCYCLIC COMPOUNDS AS AGONISTS FOR THE THYROID RECEPTOR | KARO BIO AB (SE) | 2008-03-19 | — | — | EP | disclosed |
| WO-2007003419-A1 | HETEROCYCLIC COMPOUNDS AS AGONISTS FOR THE THYROID RECEPTOR | KARO BIO AB (SE) | 2007-01-11 | — | — | WO | disclosed |